127 related articles for article (PubMed ID: 6210646)
1. Role of blood transfusions on the induction of antibodies against recognition sites on T lymphocytes in renal transplant patients.
Singal DP; Joseph S
Hum Immunol; 1982 Apr; 4(2):93-108. PubMed ID: 6210646
[TBL] [Abstract][Full Text] [Related]
2. Role of MLC serum inhibitory factors in high MLC-reactive kidney transplant recipients pretreated with donor-specific blood transfusion (DST).
Sakagami K; Takeuchi H; Matsumoto T; Tsuboi K; Ohsaki H; Tanaka K; Ohiwa K; Orita K
Jpn J Surg; 1986 Sep; 16(5):318-22. PubMed ID: 2948045
[TBL] [Abstract][Full Text] [Related]
3. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
4. The fetus as an allograft: evidence for antiidiotypic antibodies induced by pregnancy.
Singal DP; Butler L; Liao SK; Joseph S
Am J Reprod Immunol (1980); 1984 Dec; 6(4):145-51. PubMed ID: 6241427
[TBL] [Abstract][Full Text] [Related]
5. Induction of antibodies by blood transfusions capable of inhibiting responses in MLC.
Nagarkatti PS; Joseph S; Singal DP
Transplantation; 1983 Dec; 36(6):695-9. PubMed ID: 6229073
[TBL] [Abstract][Full Text] [Related]
6. IgG alloantibody responses to donor-specific blood transfusion in different rat strain combinations as a predictor of renal allograft survival.
Wasowska B; Baldwin WM; Sanfilippo F
Transplantation; 1992 Jan; 53(1):175-80. PubMed ID: 1370737
[TBL] [Abstract][Full Text] [Related]
7. Acute Rejection, Kidney Allograft Function, and Graft Survival in Patients with Circulating Pre-Transplant IgG Antibodies Directed Against Donor HLA-A, -B, or -C Locus Determined Antigens.
Abuhelaiqa E; Friedlander R; Aull M; Putheti P; Sharma V; Suthanthiran M; Dadhania D
Clin Transpl; 2016; 32():83-91. PubMed ID: 28564525
[TBL] [Abstract][Full Text] [Related]
8. Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies.
Singal DP; Blajchman MA; Joseph S; Roberge B; Smith EK; Ludwin D
Clin Exp Immunol; 1988 May; 72(2):222-7. PubMed ID: 2970351
[TBL] [Abstract][Full Text] [Related]
9. Blood-transfusion-induced suppression of cytotoxic T lymphocyte responses in mice.
Nagarkatti PS; Singal DP
Transplantation; 1983 Nov; 36(5):520-5. PubMed ID: 6227113
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of donor-specific blood transfusions (DST) on living-related kidney allograft survival.
Sakagami K; Takeuchi H; Tsuboi K; Matsumoto T; Tanaka K; Ohsaki T; Horimi T; Fuchimoto S; Orita K
Acta Med Okayama; 1986 Feb; 40(1):39-43. PubMed ID: 2938423
[TBL] [Abstract][Full Text] [Related]
11. Role of donor specific blood transfusions in prolongation of kidney graft survival.
Matsumoto T; Sakagami K; Orita K
Transplant Proc; 1987 Feb; 19(1 Pt 3):2264-7. PubMed ID: 2950636
[No Abstract] [Full Text] [Related]
12. Selective effect of noncytotoxic blocking alloantibodies produced after platelet transfusions on MLC, and mitogen and soluble antigen-induced responses of human lymphocytes.
Horuzsko A; Gyódi E; Réti M; Mayer K; Kassay M; Petrányi G
Transplantation; 1990 Sep; 50(3):497-501. PubMed ID: 2144926
[TBL] [Abstract][Full Text] [Related]
13. Pretransplant donor specific blood transfusions for one haplotype stimulatory mixed lymphocyte culture living related donor transplants.
Steinmuller D; Flechner SM; Novick AC; Braun WE; Buszta C
Am J Kidney Dis; 1982 May; 1(6):364-6. PubMed ID: 6211976
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR matched transfusions: development of donor-specific T- and B-cell antibodies and renal allograft outcome.
Christiaans MH; van Hooff JP; Nieman F; van den Berg-Loonen EM
Transplantation; 1999 Apr; 67(7):1029-35. PubMed ID: 10221489
[TBL] [Abstract][Full Text] [Related]
15. Improved renal allograft survival following donor-specific transfusions. II. In vitro correlates of early (DST-type) rejection episodes.
Burlingham WJ; Grailer A; Sparks-Mackety EM; Sondel PM; Sollinger HW
Transplantation; 1987 Jan; 43(1):41-6. PubMed ID: 2948309
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the mixed leucocyte culture reaction by plasma from renal transplatn recipients.
Singal DP; Younglai EV; Naipaul N
Tissue Antigens; 1975 Feb; 5(1):19-25. PubMed ID: 124479
[TBL] [Abstract][Full Text] [Related]
17. Non-cytotoxic blocking antibodies and suppressor cells induced by donor-specific transfusions in healthy volunteers and potential kidney transplant recipients.
Horuzsko A; Gyódi E; Réti M; Onody K; Perner F; Kassay M; Petrányi GG
Immunol Lett; 1990 Nov; 26(2):127-30. PubMed ID: 2148542
[TBL] [Abstract][Full Text] [Related]
18. MLC-inhibiting antibodies in mice after blood transfusions.
Ludwin D; Joseph S; Singal DP
Transplantation; 1986 Jan; 41(1):100-4. PubMed ID: 2934875
[TBL] [Abstract][Full Text] [Related]
19. Blastogenic suppression and alloantibody activity of sera from renal allograft recipients.
Johnson AH; Rossen RD; Hersh EM; Farrow SS; Butler WT; Suki WN
J Clin Invest; 1974 Jan; 53(1):270-8. PubMed ID: 4271573
[TBL] [Abstract][Full Text] [Related]
20. Improved renal allograft survival following donor-specific transfusions. I. Induction of antibodies that inhibit primary antidonor MLC response.
Burlingham WJ; Sparks EM; Sondel PM; Glass NR; Belzer FO; Sollinger HW
Transplantation; 1985 Jan; 39(1):12-7. PubMed ID: 3155578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
